Literature DB >> 17570417

Validation of the overactive bladder symptom score.

Jerry G Blaivas1, Georgia Panagopoulos, Jeffrey P Weiss, Chandra Somaroo.   

Abstract

PURPOSE: We validated a new 7-item overactive bladder symptom score.
MATERIALS AND METHODS: Normal subjects and consecutive patients with lower urinary tract symptoms with or without overactive bladder were recruited and classified into 3 groups based on their response to the question on an intake questionnaire, "Do you ever experience a sudden urge to urinate that makes you want to stop what you are doing and rush to a bathroom?" Subjects completed the written questionnaire in privacy on 2 occasions.
RESULTS: There were 84 subjects, including 33 men and 51 women, with a median age of 62 years (range 18 to 88). Of the subjects 33 (39%) had overactive bladder, 30 (36%) had lower urinary tract symptoms without overactive bladder and 21 (25%) were normal. There was a high level of internal consistency at visits 1 and 2 (Cronbach's alpha = 0.83 and 0.80, respectively, p <0.001). For test-retest reliability Spearman's rank order correlation coefficients for the items were r = 0.72 to 0.79 (p <0.001). A strong correlation was also observed between the total 7-item scores at visits 1 and 2 for each diagnostic subgroup, and for all participants (r = 0.86, p <0.001). Discriminant validity was established by determining significant differences in responses among the 3 subgroups at each administration (p <0.01).
CONCLUSIONS: The overactive bladder symptom score is a valid instrument that assesses all aspects of overactive bladder. It may be used as a symptom score.

Entities:  

Mesh:

Year:  2007        PMID: 17570417     DOI: 10.1016/j.juro.2007.03.133

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Urinary symptoms after bladder flap at the time of primary cesarean delivery: a randomized controlled trial (RTC).

Authors:  Amy L O'Boyle; Bethany M Mulla; Shannon V Lamb; Joy A Greer; Stuart H Shippey; Nanette L Rollene
Journal:  Int Urogynecol J       Date:  2017-06-02       Impact factor: 2.894

2.  Burch Retropubic Urethropexy Compared With Midurethral Sling With Concurrent Sacrocolpopexy: A Randomized Controlled Trial.

Authors:  Emanuel C Trabuco; Christopher J Klingele; Roberta E Blandon; John A Occhino; Amy L Weaver; Michaela E McGree; Maureen A Lemens; John B Gebhart
Journal:  Obstet Gynecol       Date:  2016-10       Impact factor: 7.661

3.  Urogynecological conditions associated with overactive bladder symptoms in women.

Authors:  James C Forde; Jonathan L Davila; Brian K Marks; Matthew Epstein; Johnson F Tsui; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

4.  [Diagnosis of overactive bladder (OAB)].

Authors:  M Kurosch; R Mager; K Gust; M Brandt; H Borgmann; A Haferkamp
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

5.  Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.

Authors:  Seung Hwan Lee; Seok Soo Byun; Seung Ju Lee; Khae Hawn Kim; Ji Youl Lee
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

6.  The Factors Affecting Lower Urinary Tract Functions in Patients Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Haci Murat Cayci; Sedat Oner; Umut Eren Erdogdu; İdris Nas; Evren Dilektasli; Murat Demirbas
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

7.  THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

Authors:  Giorgia Teresa Maniscalco; R Aponte; D Bruzzese; G Guarcello; V Manzo; M Napolitano; O Moreggia; F Chiariello; C Florio
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

8.  Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections.

Authors:  Maryam Emami; Pejman Shadpour; Amir H Kashi; Masoud Choopani; Mohammadreza Zeighami
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

9.  Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder: A prospective, randomized controlled, crossover-design, pilot study.

Authors:  Hye-Yoon Lee; Young-Ju Yun; Jun-Yong Choi; Jin-Woo Hong; In Lee; Seong-Ha Park; Jung-Nam Kwon
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Effectiveness of neuromuscular electrical stimulation therapy in patients with urinary incontinence after stroke: A randomized sham controlled trial.

Authors:  Gai-Yan Guo; Yong-Gang Kang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.